Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

747375

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what action they are taking to improve mental health services for young people.
tabling member printed	Lord Eames
uin	HL339
answer	answer is ministerial correction date of answer 17/07/2017 answer text <p>We are making an additional £1.4 billion available up until 2020/21 to improve the provision of children and young people’s mental health services, including £150 million specifically to tackle eating disorders.</p><p> </p><p>This funding is delivering a major system-wide transformation programme to improve access and make services more widely available across the country, and implementing the vision set out in <em>Future in Mind. </em>To this end all clinical commissioning groups working with their partners, developed transformation plans for children’s and young people’s mental health in 2015/16, incorporating them last year into their wider NHS Sustainability and Transformation Plans. These set out how local agencies are working together to improve children and young people’s mental health across the full spectrum of need.</p><p> </p><p>Later this year, the Government will publish a Green Paper on children and young people’s mental health focused on helping young people receive the best start in life. The Green Paper will have two core themes: preventing mental ill-health and ensuring better access to services.</p> answering member printed Lord O'Shaughnessy question first answered 17/07/2017 11:51:38 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2793 label Biography information for Lord Eames

747416

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government when they will publish their response to the Accelerated Access Review of innovative medicines and medical technologies.
tabling member printed	Lord Lansley
uin	HL380
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.</p><p> </p><p>The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review’s recommendations and will respond in due course.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL381 HL383 question first answered 11/07/2017 13:59:51 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	123 label Biography information for Lord Lansley

747417

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether they intend to establish the Accelerated Access Partnership as recommended in their Accelerated Access Review; and if so when.
tabling member printed	Lord Lansley
uin	HL381
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.</p><p> </p><p>The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review’s recommendations and will respond in due course.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL380 HL383 question first answered 11/07/2017 13:59:51 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	123 label Biography information for Lord Lansley

747418

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether a strategic commercial unit will be established within NHS England, as recommended in the Accelerated Access Review, and if so, when.
tabling member printed	Lord Lansley
uin	HL382
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>Consistent with recommendations set out in the Accelerated Access Review, NHS England continues to develop its commercial capacity and capability in relation to medicines procurement as well as the negotiation of bespoke commercial access arrangements for high cost drugs. As part of this, the Commercial Medicines Unit transferred across from the Department to NHS England on 1 April 2017. NHS England is currently in the process of recruiting to a number of other key posts to support the commercial function more broadly.</p> answering member printed Lord O'Shaughnessy question first answered 11/07/2017 14:30:38 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	123 label Biography information for Lord Lansley

747419

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what plans they have to introduce a "transformative designation", as proposed in the Accelerated Access Review, for the most strategically important products for the NHS.
tabling member printed	Lord Lansley
uin	HL383
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.</p><p> </p><p>The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review’s recommendations and will respond in due course.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL380 HL381 question first answered 11/07/2017 13:59:51 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	123 label Biography information for Lord Lansley

747424

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether they intend to introduce legislation to repeal (1) sections 58 and 59 of the Offences Against the Person Act 1861, and (2) section 25 of the Criminal Justice (Northern Ireland) Act as amended; and, if not, why not.
tabling member printed	Lord Lester of Herne Hill
uin	HL388
answer	answer is ministerial correction date of answer 14/07/2017 answer text <p>The Government has no plans to repeal sections 58 and 59 of the Offences Against the Person Act 1861. As with other matters of conscience, abortion is an issue on which the Government adopts a neutral stance and allows Members to vote according to their moral, ethical or religious beliefs. Traditionally any proposals for legislative change are a matter for backbenchers to bring forward and there is a free vote in both Houses of Parliament.</p><p> </p><p>There are no plans to repeal section 25 of the Criminal Justice (Northern Ireland) Act. The law on abortion in Northern Ireland is a matter for the Northern Ireland Executive and Assembly.</p> answering member printed Lord O'Shaughnessy question first answered 14/07/2017 12:43:42 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2037 label Biography information for Lord Lester of Herne Hill

747465

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sustainability and Transformation Partnerships: Bassetlaw and South Yorkshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what costs have been (a) incurred to date and (b) committed for future periods for the development and management of the South Yorkshire and Bassetlaw Sustainability and Transformation Plan.
tabling member constituency	Barnsley East
tabling member printed	Stephanie Peacock
uin	2652
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>Sustainability and Transformation Partnerships (STP) have been developed by local areas. In South Yorkshire and Bassetlaw this includes eight clinical commissioning groups, and multiple National Health Service provider trusts and local authorities. These partners are contributing from their own staff resources to support the multiple programmes and work streams set out in the plan, and staff are working on the STP in addition to their other management roles. As a result, we do not hold the total cost of developing the STP.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/07/2017 15:40:56 answering member 4067 label Biography information for Steve Brine
tabling member	4607 label Biography information for Stephanie Peacock

747515

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Streptococcus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress his Department has made on reviewing UK National Screening Committee guidance on Group B strep prevention; and if he will make a statement.
tabling member constituency	Mid Sussex
tabling member printed	Sir Nicholas Soames
uin	2421
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>The United Kingdom National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy, using research evidence, pilot programmes and economic evaluation; it assesses the evidence for programmes against a set of internationally recognised criteria. Guidance on early onset neonatal Group B Streptococcus (GBS) and other neonatal disease is provided by the Royal College of Obstetricians and Gynaecologists and National Institute for Health and Care Excellence.</p><p> </p><p>Following the UK NSC’s meeting in February 2017, the Minister accepted the UK NSC’s recommendation that a population based screening programme for GBS carriage should not be offered. This is because there is insufficient evidence to demonstrate that the benefits to be gained from screening would outweigh the harms.</p><p> </p><p>Although a population screening programme has not been recommended, the Chief Scientific Advisor recommended that the National Institute of Health Research should commission a clinical trial to compare universal screening for GBS against usual-risk based care. The Minister approved this and it is expected that the trial will provide better quality evidence to assess the clinical effectiveness, benefits and harms of a screening programme.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 2420 question first answered 06/07/2017 14:06:12 answering member 1542 label Biography information for Philip Dunne
tabling member	116 label Biography information for Lord Soames of Fletching

747518

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Streptococcus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the National Institute for Health Research will begin the clinical trial comparing universal screening for Group B strep carriage in late pregnancy with usual risk-based care.
tabling member constituency	Mid Sussex
tabling member printed	Sir Nicholas Soames
uin	2419
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>The National Institute for Health Research will launch the expression of interest for the trial to compare universal screening for Group B strep carriage in late pregnancy with usual risk-based care shortly. Following a full Health Technology Assessment board commissioning process, it is anticipated that the pilot phase of the trial will start at the beginning of 2019.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 06/07/2017 14:08:43 answering member 1542 label Biography information for Philip Dunne
tabling member	116 label Biography information for Lord Soames of Fletching

747519

registered interest
date	03/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Streptococcus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to review Group B strep prevention strategies to align the UK with international best practice in preventing early-onset Group B Strep.
tabling member constituency	Mid Sussex
tabling member printed	Sir Nicholas Soames
uin	2420
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>The United Kingdom National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy, using research evidence, pilot programmes and economic evaluation; it assesses the evidence for programmes against a set of internationally recognised criteria. Guidance on early onset neonatal Group B Streptococcus (GBS) and other neonatal disease is provided by the Royal College of Obstetricians and Gynaecologists and National Institute for Health and Care Excellence.</p><p> </p><p>Following the UK NSC’s meeting in February 2017, the Minister accepted the UK NSC’s recommendation that a population based screening programme for GBS carriage should not be offered. This is because there is insufficient evidence to demonstrate that the benefits to be gained from screening would outweigh the harms.</p><p> </p><p>Although a population screening programme has not been recommended, the Chief Scientific Advisor recommended that the National Institute of Health Research should commission a clinical trial to compare universal screening for GBS against usual-risk based care. The Minister approved this and it is expected that the trial will provide better quality evidence to assess the clinical effectiveness, benefits and harms of a screening programme.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 2421 question first answered 06/07/2017 14:06:12 answering member 1542 label Biography information for Philip Dunne
tabling member	116 label Biography information for Lord Soames of Fletching